Cargando…
Reasons physicians do not recommend and patients refuse adjuvant chemotherapy for stage III colon cancer: a population based chart review
BACKGROUND: Surgery followed by adjuvant chemotherapy has been the standard of care for the treatment of stage III colon cancer since the early 1990’s. Despite this, large proportions of patients do not receive adjuvant chemotherapy. We aimed to identify physicians’ and patients’ reasons for treatme...
Autores principales: | El Shayeb, Mohamed, Scarfe, Andrew, Yasui, Yutaka, Winget, Marcy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3405463/ https://www.ncbi.nlm.nih.gov/pubmed/22676354 http://dx.doi.org/10.1186/1756-0500-5-269 |
Ejemplares similares
-
Diabetes alone should not be a reason for withholding adjuvant chemotherapy for stage III colon cancer
por: van Waalwijk, Maren A., et al.
Publicado: (2011) -
Efficacy, Compliance and Reasons for Refusal of Postoperative Chemotherapy for Elderly Patients with Colorectal Cancer: A Retrospective Chart Review and Telephone Patient Questionnaire
por: Li, Pan, et al.
Publicado: (2013) -
Adjuvant Chemotherapy for Stage III Colon Cancer
por: Taieb, Julien, et al.
Publicado: (2020) -
Re-excision and survival following breast conserving surgery in early stage breast cancer patients: a population-based study
por: Fisher, Stacey, et al.
Publicado: (2018) -
Adjuvant immunotherapy recommendations for stage III melanoma: physician and nurse interviews
por: Livingstone, Ann, et al.
Publicado: (2021)